Research Article| Volume 16, ISSUE 3, P513-525, September 1996

The Mycobacteriology Laboratory: Past, Present, and Future

  • Leonid B. Heifets
    Address reprint requests to: Leonid B. Heifets, MD, PhD, ScD, National Jewish Center for Immunology and Respiratory Medicine, 1400 Jackson Street, Denver, CO 80206
    From the Mycobacteriology Laboratory, National Jewish Center for Immunology and Respiratory Medicine; and the Department of Microbiology, University of Colorado Health Sciences Center, Denver, Colorado
    Search for articles by this author
      This paper is only available as a PDF. To read, Please Download here.
      The role of the mycobacteriology laboratory in tuberculosis control programs has been underestimated in the past, but now laboratory services are proven to play an essential role if properly implemented. The importance and reliability of these services in the future will depend on their centralization in specialized mycobacteriology laboratories that will be able to put new technologies into practice. The shortest turnaround time and the greatest cost effectiveness can be achieved by direct submission of raw specimens to such laboratories, especially for the management of new tuberculosis patients.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.

      Content published before 2002 is available via pay-per-view purchase only.


      Subscribe to Clinics in Laboratory Medicine
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • American Thoracic Society
        Diagnostic standards and classification of tuberculosis.
        Am Rev Respir Med. 1990; 142: 725-735
        • American Thoracic Society
        Levels of laboratory services.
        Am Rev Respir Dis. 1983; 128: 213-215
        • Angerano G.
        • Carbonara D.
        • Costa D.
        • et al.
        Drug resistance of M. tuberculosis strains isolated from HIV-infected Italian patients: Preliminary report from a multicenter study.
        Microbiologica. 1995; 18: 69-72
        • Bailey G.V.J.
        • Savic D.
        • Gothi G.D.
        • et al.
        Potential yield of pulmonary tuberculosis cases by direct microscopy of an acid-fast bacilli.
        Rev Infect Dis. 1967; 6: 214-222
        • Beilin E.
        Failure of tuberculosis control. A prescription for change [editorial].
        JAMA. 1994; 271: 708-709
        • Bloch A.B.
        • Cauthen G.M.
        • Onorato I.M.
        Nationwide survey of drug-resistant tuberculosis in the United States.
        JAMA. 1994; 271: 665-671
        • Bloom B.R.
        • Murray C.J.
        Tuberculosis: Commentary on a reemerging killer.
        Science. 1993; 257: 1055-1064
        • Brudney K.
        • Dobkin J.
        Resurgent tuberculosis in New York City: HIV, homelessness, and decline of tuberculosis control programs.
        Am Rev Respir Dis. 1991; 144: 745-749
        • Canetti G.
        • Fox W.
        • Khomenko A.
        • et al.
        Advances in techniques of testing mycobacterial drug sensitivity and the use of sensitivity tests in tuberculosis control programs.
        Bull World Health Organ. 1969; 41: 21-43
        • Centers for Disease Control and Prevention
        Tuberculosis Morbidity, Weekly Report.
        MMWR. 1992; 42: 696-704
        • Cernoch P.L.
        • Enns R.K.
        • Saubolle M.A.
        • Wallace R.J.
        Laboratory diagnosis of the mycobac-terioses.
        in: Weissfield AS Cumulative Techniques and Procedures in Clinical Microbiology (Cumitech 16A). American Society for Microbiology, Washington, DC1994
        • Dolin P.J.
        • Raviglione M.D.
        • Kochi A.
        Global tuberculosis incidence and mortality during 1990-2000.
        Bull World Health Organ. 1993; 72: 213-220
        • Edlin B.R.
        • Tokars J.I.
        • Grieco M.H.
        An outbreak of multidrug resistant tuberculosis among hospitalized patients with acquired immunodeficiency syndrome.
        N Engl J Med. 1992; 326: 1514-1521
        • Enarson D.A.
        The International Union Against Tuberculosis and Lung Disease model National Tuberculosis Programmes.
        Tuber Lung Dis. 1995; 76: 95-99
        • Fischl M.A.
        • Uttamchandani R.B.
        • Daikos G.L.
        An outbreak of tuberculosis caused by multiple-drug resistant tubercle bacilli among patients with HIV infection.
        Ann Intern Med. 1992; 117: 177-183
        • Forbes B.A.
        • Hicks K.E.
        Direct detection of Mycobacterium tuberculosis in respiratory specimens in a clinical laboratory by polymerase chain reaction.
        J Clin Microbiol. 1993; 31: 1688-1694
        • Frieden T.
        • Sterling T.
        • Pablos-Mendez A.
        • et al.
        The emergence of drug-resistant tuberculosis in New York City.
        N Engl J Med. 1993; 328: 521-526
        • Grosset J.
        • Mouton Y.
        Is PCR a useful tool for the diagnosis of tuberculosis in 1995?.
        Tuber Lung Dis. 1995; 1: 183-184
        • Hopewell P.C.
        Impact of HIV on the epidemiology, clinical features, management, and control of tuberculosis.
        Clin Infect. 1992; 15: 540-547
        • Horsburgh Jr, CR
        • Havlik J.A.
        • Ellis D.A.
        Survival of AIDS patients with disseminated Mycobacterium avium complex infection with and without antimycobacterial chemotherapy.
        American Review of Respiratory Disease. 1991; 144: 557-559
        • Kleeberg H.H.
        A simple method for testing the drug susceptibility of M. tuberculosis, a report of an international collaborative study.
        Bull Intern Union Against Tuber. 1985; 60: 147-153
        • Kochi A.
        The global tuberculosis situation and the new control strategy of the World Health Organization.
        Tubercle. 1991; 72: 1-6
        • Kubica G.P.
        • Gross W.M.
        • Hawkins J.E.
        • et al.
        Laboratory services for mycobacterial diseases.
        Am Rev Respir Dis. 1975; 112: 773-787
        • Nightingale S.D.
        • Byrd L.T.
        • Southern P.M.
        • et al.
        Incidence of Mycobacterium avium-intracellulare complex bacteremia in human immunodeficiency virus-positive paitents.
        J Infect Dis. 1992; 165: 1082-1085
        • Slutkin G.
        • Leowski J.
        • Mann J.
        Tuberculosis and AIDS: the effects of the AIDS epidemic on tuberculosis problems and tuberculosis programmes.
        Bull Intern Union Tuber Lung Dis. 1986; 63: 21-24
        • Snider Jr, DE
        • Raviglione M.
        • Kochi A.
        Global burden of tuberculosis.
        in: Bloom BR Tuberculosis: Pathogenesis, Protection and Control. ASM Press, Washington, DC1994
        • Sommers H.M.
        • McClatchy J.K.
        Cumitech 16, Laboratory diagnosis of the mycobacterioses.
        in: Morello JA Cumulative Techniques and Procedures in Clinical Microbiology (Cumitech 16). American Society for Microbiology, Washington, DC1983
        • Styblo K.
        The potential impact of AIDS on the tuberculosis situation in developed and developing countries.
        Bull Intern Union Tuber Lung Dis. 1988; 63: 25-28
        • Sudre P.
        • ten Dam H.G.
        • Kochi A.
        Tuberculosis: A global overview of the situation today.
        Bull World Health Organ. 1992; 70: 149-159
        • Tenover F.C.
        • Crawford J.T.
        • Heubner R.E.
        • et al.
        The resurgence of tuberculosis: Is your laboratory ready?.
        J Clin Microbiol. 1993; 31: 767-770
      1. World Health Organization: Fifth report, technical report series no. 607, 1977

      2. World Health Organization: TB epidemic outpaces new drug development, 1994